Clinical Trial Update: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is planned to evaluate the efficacy of TQA3038 Injection for chronic hepatitis B, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TQA3038 Injection

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hepatitis B, Chronic | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING